Oncology Newswire

Oncology Newswire

Comprehensive Real-Time News Feed for Oncology.

Results 1 - 20 of 26,672 in Oncology

  1. Cancer Genetics (CGIX) Trading 11.5% HigherRead the original story w/Photo

    1 hr ago | Daily Political

    ... to diagnose, monitor, and inform cancer treatment; and enable biotech and pharmaceutical companies involved in oncology and immuno-oncology trials to select candidate populations and reduce adverse drug reactions by providing information regarding ...

    Comment?

  2. Eagle Pharmaceuticals Inc (EGRX) Given Average Recommendation of "Buy" by AnalystsRead the original story w/Photo

    1 hr ago | AmericanBankingNews.com

    ... company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company offers argatroban for heparin-induced thrombocytopenia; Ryanodex for malignant hyperthermia; ...

    Comment?

  3. Shire PLC (SHP) Given Consensus Rating of "Buy" by AnalystsRead the original story w/Photo

    1 hr ago | AmericanBankingNews.com

    ... areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology. Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news ...

    Comment?

  4. Hundreds of Irish patients to take part in five-year trial to see if...Read the original story w/Photo

    1 hr ago | BreakingNews.ie

    ... which is supported by the Irish Cancer Society and Health Research Board. Dr Gregory Leonard - Consultant Medical Oncology at Galway University Hospital - is the chief investigator for the double-blind, placebo-controlled and randomised trial here ...

    Comment?

  5. Shire PLC (SHP) Receives Average Recommendation of a oeBuya from BrokeragesRead the original story w/Photo

    2 hrs ago | The Breeze

    ... areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology. Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news ...

    Comment?

  6. Waddell & Reed Financial Inc. Acquires New Stake in Forty Seven IncRead the original story w/Photo

    2 hrs ago | Daily Political

    ... that Forty Seven Inc will post -2.96 EPS for the current fiscal year. Forty Seven Inc, a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized ...

    Comment?

  7. Steigerwald Gordon & Koch Inc. Boosts Position in Amgen, Inc.Read the original story w/Photo

    3 hrs ago | AmericanBankingNews.com

    ... develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to ...

    Comment?

  8. NeoGenomics (NEO) Raised to Strong-Buy at BidaskClubRead the original story w/Photo

    3 hrs ago | Daily Political

    A number of other analysts have also recently commented on NEO. Stephens reissued a "buy" rating and issued a $15.00 price target on shares of NeoGenomics in a research report on Tuesday, June 26th.

    Comment?

  9. Corvus Pharmaceuticals (CRVS) Downgraded to "Sell" at BidaskClubRead the original story w/Photo

    3 hrs ago | Daily Political

    ... Inc, a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies that are designed to harness the immune system to attack cancer cells. Its lead product candidate is CPI-444, an oral, ...

    Comment?

  10. Aslan Pharmaceuticals Adr Rep 5 (Asln) Downgraded by Zacks Investment ResearchRead the original story w/Photo

    3 hrs ago | IntersportsWire

    According to Zacks, "ASLAN Pharmaceuticals Limited operates as a clinical-stage biotechnology company. It develops drugs, medicines and novel therapeutics for the treatment of patients with oncology, respiratory and inflammatory diseases.

    Comment?

  11. Verastem Inc (VSTM) Receives Consensus Recommendation of "Buy" from AnalystsRead the original story w/Photo

    3 hrs ago | AmericanBankingNews.com

    ... company's lead FAK inhibitor is defactinib, an orally available candidate for combination therapy with immuno-oncology agents and other anti-cancer compounds. Receive News & Ratings for Verastem Daily - Enter your email address below to receive ...

    Comment?

  12. Proof-of-concept HIV immunotherapy study passes Phase 1 safety trialRead the original story

    Friday | Science Daily

    ... Since these earlier attempts, the adoptive-T-cell-therapy field has made significant advances, largely in the oncology field, that could help to overcome some of the pitfalls encountered with earlier T-cell-therapy approaches for HIV. T cells ...

    Comment?

  13. -$0.14 EPS Expected for Moleculin Biotech Inc (MBRX) This QuarterRead the original story w/Photo

    4 hrs ago | Daily Political

    ... investors. Moleculin Biotech, Inc, a clinical-stage pharmaceutical company, focuses on the development of oncology drug candidates. Its lead drug candidate is liposomal Annamycin, an anthracycline intended for the treatment of relapsed or refractory ...

    Comment?

  14. Macquarie Group Ltd. Purchases 1,500 Shares of Mirati Therapeutics IncRead the original story w/Photo

    5 hrs ago | Daily Political

    ... has a consensus rating of "Buy" and an average price target of $52.00. Mirati Therapeutics, Inc, a clinical-stage oncology company, develops targeted therapeutics to address the genetic, epigenetic, and immunological promoters of cancer. The company ...

    Comment?

  15. Too Young To Die, Chapter SixRead the original story w/Photo

    6 hrs ago | Daily News

    He was nervous; there was no getting around it. Ron Kopytko knew this moment was coming for days and had gone over it a million times in his head, sorting out all the steps, playing out every possible angle.

    Comment?

  16. Fmr LLC Has $61.27 Million Position in Kura Oncology IncRead the original story w/Photo

    6 hrs ago | AmericanBankingNews.com

    Fmr LLC reduced its position in shares of Kura Oncology Inc by 24.1% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,366,419 shares of the company's stock after selling 1,067,096 shares during the period.

    Comment?

  17. Trial to test whether aspirin can prevent cancer returnRead the original story w/Photo

    7 hrs ago | RTE.ie

    ... worldwide to stop or slow cancer is potentially ground breaking," said Dr Gregory Leonard, Consultant Medical Oncology, Galway University Hospital and the trial's Chief Investigator for Ireland. The results of this trial could have a huge impact on ...

    Comment?

  18. Immune Pharmaceuticals (IMNP) and vTv Therapeutics (VTVT) Critical ReviewRead the original story w/Photo

    7 hrs ago | IntersportsWire

    ... and ketamine for the treatment of postherpetic neuralgia and diabetic peripheral neuropathy. Further, its oncology portfolio comprises Ceplene, for the maintenance of remission in patients with acute myeloid leukemia in combination with ...

    Comment?

  19. Financial Comparison: FluidigmRead the original story w/Photo

    7 hrs ago | IntersportsWire

    ... the Asia-Pacific region, the Middle East, and South Africa. The company has a strategic partnership with Loxo Oncology, Inc. to develop and commercialize a multi-gene panel for broad tumor profiling; and strategic collaboration with Bristol-Myers ...

    Comment?

  20. Nektar Therapeutics (NKTR) Stake Decreased by PNC Financial Services Group Inc.Read the original story w/Photo

    7 hrs ago | Daily Political

    ... ne diseases; and NKTR-262 for solid tumors, as well as NKTR-255 that is under research/preclinical stage for immuno-oncology. Want to see what other hedge funds are holding

    Comment?